相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Detection of Low-Level K65R Variants in Nucleoside Reverse Transcriptase Inhibitor-Naive Chronic and Acute HIV-1 Subtype C Infections
Jin-fen Li et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Analysis of RT Sequences of Subtype C HIV-Type 1 Isolates from Indian Patients at Failure of a First-Line Treatment According to Clinical and/or Immunological WHO Guidelines
Alaka Deshpande et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2010)
Development of an Allele-Specific PCR for Detection of the K65R Resistance Mutation in Patients Infected with Subtype C Human Immunodeficiency Virus Type 1
Thomas A. Toni et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
International Cohort Analysis of the Antiviral Activities of Zidovudine and Tenofovir in the Presence of the K65R Mutation in Reverse Transcriptase
Philip M. Grant et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Nucleic Acid Template and the Risk of a PCR-Induced HIV-1 Drug Resistance Mutation
Vici Varghese et al.
PLOS ONE (2010)
The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy
Mina C. Hosseinipour et al.
AIDS (2009)
Structural Basis for the Role of the K65R Mutation in HIV-1 Reverse Transcriptase Polymerization, Excision Antagonism, and Tenofovir Resistance
Kalyan Das et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Signature Nucleotide Polymorphisms at Positions 64 and 65 in Reverse Transcriptase Favor the Selection of the K65R Resistance Mutation in HIV-1 Subtype C
Cedric F. Invernizzi et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Prevalence of the K65R Resistance Reverse Transcriptase Mutation in Different HIV-1 Subtypes in Israel
Dan Turner et al.
JOURNAL OF MEDICAL VIROLOGY (2009)
Increased Thermostability and Fidelity of DNA Synthesis of Wild-Type and Mutant HIV-1 Group O Reverse Transcriptases
Mar Alvarez et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Template Usage Is Responsible for the Preferential Acquisition of the K65R Reverse Transcriptase Mutation in Subtype C Variants of Human Immunodeficiency Virus Type 1
Dimitrios Coutsinos et al.
JOURNAL OF VIROLOGY (2009)
Architecture and secondary structure of an entire HIV-1 RNA genome
Joseph M. Watts et al.
NATURE (2009)
A new human immunodeficiency virus derived from gorillas
Jean-Christophe Plantier et al.
NATURE MEDICINE (2009)
Effects of the K65R and K65R/M184V reverse transcriptase mutations in subtype C HIV on enzyme function and drug resistance
Hong-Tao Xu et al.
RETROVIROLOGY (2009)
HIV Type 1 Subtype C Drug Resistance among Pediatric and Adult South African Patients Failing Antiretroviral Therapy
Visva Pillay et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2008)
Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naive populations and associate with reduced treatment efficacy
Jeffrey A. Johnson et al.
PLOS MEDICINE (2008)
Molecular basis of antagonism between K70E and K65R tenofovir-associated mutations in HIV-1 reverse transcriptase
R. M. Kagan et al.
ANTIVIRAL RESEARCH (2007)
Molecular mechanisms of bidirectional antagonism between K65R and thymidine analog mutations in HIV-1 reverse transcriptase
Urvi M. Parikh et al.
AIDS (2007)
Changing rates and patterns of drug resistance mutations in antiretroviral-experienced HIV-infected patients
Carmen De Mendoza et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2007)
High rates of forward transmission events after acute/early HIV-1 infection
Bluma G. Brenner et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Diminished efficiency of HIV-1 reverse transcriptase containing the K65R and M184V drug resistance mutations
Fernando A. Frankel et al.
AIDS (2007)
Is HIV-1 evolving to a less virulent form in humans?
Kevin K. Arien et al.
NATURE REVIEWS MICROBIOLOGY (2007)
Molecular mechanism by which the K70E mutation in human immunodeficiency virus type 1 reverse transcriptase confers resistance to nucleoside reverse transcriptase inhibitors
Nicolas Sluis-Cremer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
High prevalence of the K65R mutation in human immunodeficiency virus type 1 subtype C isolates from infected patients in Botswana treated with didanosine-based regimens
Florence Doualla-Bell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Resistance development over 144 weeks in treatment-naive patients receiving tenofovir disoproxil fumarate or stavudine with lamivudine and efavirenz in Study 903
N. A. Margot et al.
HIV MEDICINE (2006)
Antagonism between the HIV-1 reverse-transcriptase mutation K65R and thymidine-analogue mutations at the genomic level
Urvi M. Parikh et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Origins of HIV and the evolution of resistance to AIDS
Jonathan L. Heeney et al.
SCIENCE (2006)
Chimpanzee reservoirs of pandemic and nonpandemic HIV-1
Brandon F. Keele et al.
SCIENCE (2006)
HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture
Bluma G. Brenner et al.
AIDS (2006)
The K65R mutation in human immunodeficiency virus type 1 reverse transcriptase exhibits bidirectional phenotypic antagonism with thymidine analog mutations
Urvi M. Parikh et al.
JOURNAL OF VIROLOGY (2006)
Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV
JE Gallant et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Virologic and enzymatic studies revealing the mechanism of K65R- and Q151M-associated HIV-1 drug resistance towards emtricitabine and lamivudine
JY Feng et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2006)
A combination of decreased NRTI incorporation and decreased excision determines the resistance profile of HIV-1K65R RT
KL White et al.
AIDS (2005)
Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death:: a prospective cohort study
JAC Sterne et al.
LANCET (2005)
The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates
KK Ariën et al.
JOURNAL OF VIROLOGY (2005)
Diminished replicative fitness of primary human immunodeficiency virus type 1 isolates harboring the K65R mutation
J Weber et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Medical progress: HIV drug resistance
F Clavel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Mechanistic basis for reduced viral and enzymatic fitness of HIV-1 reverse transcriptase containing both K65R and M184V mutations
J Deval et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Efficacy and safety of tenofovir DF vs stavuldine in combination therapy in antiretroviral-naive patients - A 3-year randomized trial
JE Gallant et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
A loss of viral replicative capacity correlates with altered DNA polymerization kinetics by the human immunodeficiency virus reverse transcriptase bearing the K65R and L74V dideoxynucleoside resistance substitutions
J Deval et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
A Mocroft et al.
LANCET (2003)
Comparing the ex vivo fitness of CCR5-tropic human immunodeficiency virus type 1 isolates of subtypes B and C
SC Ball et al.
JOURNAL OF VIROLOGY (2003)
Genotypic and phenotypic analyses of HIV-1 in antiretroviral-experienced patients treated with tenofovir DF
NA Margot et al.
AIDS (2002)
Human immunodeficiency virus type 1 reverse-transcriptase and protease subtypes: Classification, amino acid mutation patterns, and prevalence in a northern California clinic-based population
MJ Gonzales et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Resistance profile of the human immunodeficiency virus type 1 reverse transcriptase inhibitor abacavir (1592U89) after monotherapy and combination therapy
PR Harrigan et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
分享论文
